CLOV vs RGS · rev $1.37B vs P/E 0.6, rev $210.1M
Clover Health Investments Corp (CLOV) versus Regis Corporation Common Stock (RGS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Regis Corporation Common Stock (RGS) is a personal services company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported RGS revenue for 2025-06-30 was $210.1M. Net income was $123.5M. Revenue was up 3.5% from 2024-06-30 to 2025-06-30. RGS currently screens at market cap $56.5M and trailing P/E 0.6.
CLOV currently screens at market cap $1.55B. RGS currently screens at market cap $56.5M and trailing P/E 0.6.
Not investment advice. Open the CLOV and RGS stock pages for the full models.
Not investment advice.